Karen Godette MD
Overview
Karen Godette, MD, is Associate Professor in the Department of Radiation Oncology at Emory University School of Medicine. A board certified radiation oncologist, Dr. Godette specializes in breast malignancies, prostate cancer and soft tissue sarcoma. Within these areas, her expertise is in brachytherapy and in intraoperative radiotherapy. She treats patients at Winship at Emory University Hospital Midtown where she has served as medical director since 2001. She is also on the physician team providing care to patients at Emory Proton Therapy Center.
Dr. Godette has been featured in the news for her use of an implantable radiotherapy device that enables radiation treatment to be more precisely delivered as well as intraoperative radiation therapy for early-stage breast cancer. She played a central role in creating a radiation oncology residency program at Emory. She served for 10 years as director of the residency program. She has also served as the medical director and advisor for the Grady Radiation Therapy Technology School since 1998.
Dr. Godette is actively involved in the community and participates in health fairs, educational workshops, multidisciplinary panels and support groups. She is also active in the international arena, working in partnership with colleagues in developing countries to advance the delivery and standard of cancer care.
Dr. Godette is a member of the American Society of Therapeutic Radiology and Oncology, American Society of Clinical Oncology, Connective Tissue Oncology Society, American Medical Womens Association, American Board of Radiology and National Medical Association, where she served as chair of the radiology section from 2005-2007.
Dr. Godette was awarded the Woodruff Fund Clinical Teaching Support Award in Radiation Oncology in 2002 for her commitment to teaching.
Dr. Godette is a manuscript reviewer for the International Journal of Radiation Oncology, Biology, Physics, and Journal of Surgical Oncology. She has written or coauthored many articles, abstracts and book chapters, and has spoken at both national and international meetings.
Academic Appointment
- Associate Professor, Department of Radiation Oncology, Emory University School of Medicine
Education
Degrees
- BS from Howard University
- MD from Howard University
Research
Focus
- My research centers on breast cancer, prostate cancer, gynecological malignancies, and sarcomas-treatment, outcomes and toxicity. I am interested in the utilization of brachytherapy (LDR and HDR) and intensity modulated radiation therapy (IMRT) in the multimodality treatment of these malignancies and examining the role of PET in their treatment.
Publications
-
Intraoperative radiation therapy for early-stage breast cancer.
Volume: 130 Page(s): 997 - 1005
10/01/2024 Authors: Schwieger L; Switchenko JM; Cao Y; Amaniera I; Phillips-Reed R; Godette K; Rizzo M -
Impact of Rectal Spacer on Toxicity Reduction in Men Treated With Proton Versus Photon Therapy.
Int J Part Ther Volume: 13 Page(s): 100111
09/01/2024 Authors: Dhere VR; Goyal S; Zhou J; Sebastian NT; Patel AB; Hanasoge S; Patel PR; Shelton J; Godette KD; Hershatter BW -
Rapid unpaired CBCT-based synthetic CT for CBCT-guided adaptive radiotherapy.
J Appl Clin Med Phys Volume: 24 Page(s): e14064
10/01/2023 Authors: Wynne JF; Lei Y; Pan S; Wang T; Pasha M; Luca K; Roper J; Patel P; Patel SA; Godette K -
Radiation Facility Volume and Survival for Men With Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy.
JAMA Netw Open Volume: 6 Page(s): e2327637
08/01/2023 Authors: Sebastian N; Goyal S; Liu Y; Janopaul-Naylor JR; Patel PR; Dhere VR; Hanasoge S; Shelton JW; Godette KD; Jani AB -
Time to Radiation after Oncoplastic Reduction versus After Lumpectomy.
Plast Reconstr Surg Glob Open Volume: 11 Page(s): e4970
05/01/2023 Authors: Marxen T; Chan P; Baker N; Godette KD; Styblo TM; Carlson GW; Losken A -
Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials.
JAMA Oncol Volume: 9 Page(s): 646 - 655
05/01/2023 Authors: Wang D; Harris J; Kraybill WG; Eisenberg B; Kirsch DG; Ettinger DS; Kane JM; Barry PN; Naghavi A; Freeman CR -
Ultrasound Radiomics-Based Machine Learning to Evaluate Radiation-Induced Acute Breast Toxicity in Breast Radiotherapy
Volume: 49 Page(s): E587 - E587
06/01/2022 Authors: Wang J; Zhou B; Yang X; Lin J; Godette K; Kahn S; Torres M; Liu T -
Acute Breast Toxicity Evaluations with a Breast Ultrasound Scoring Scheme
Volume: 49 Page(s): E981 - E982
06/01/2022 Authors: Wang J; Zhou B; Yang X; Lin J; Godette K; Kahn S; Torres M; Liu T -
A Practical Approach to Transmission and Dosimetric Leaf Gap Selectionfor Two Identical Linacs for Stereotactic Radiosurgery Treatments
Volume: 49 Page(s): E783 - E783
06/01/2022 Authors: Xie H; Elder E; Ghavidel B; Charyyev S; Liu R; Liu Y; Zhang J; Luca K; Godette K; Yang X -
Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients With Pathologic Negative Nodes After Neoadjuvant Chemotherapy.
Clin Breast Cancer Volume: 22 Page(s): 127 - 135
02/01/2022 Authors: Schlafstein A; Liu Y; Goyal S; Kahn S; Godette K; Lin J; Torres MA; Royce TJ; Patel SA